BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1670651)

  • 1. Experimental reduction of portal hypertension by mechanical increase of liver portal flow.
    Habib N; Houssin D; Carol C; Cardoso J; Boisseau C; Calmus Y; Ozier Y; Quere J; Wood C; McIntyre N
    Lancet; 1991 Jan; 337(8732):16-7. PubMed ID: 1670651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the pathogenesis of portal hypertension in cirrhosis of the liver.
    Shibayama Y
    Liver; 1988 Apr; 8(2):95-9. PubMed ID: 3367713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of sinusoidal stenoses in portal hypertension of liver cirrhosis.
    Shibayama Y; Nakata K
    J Hepatol; 1989 Jan; 8(1):60-6. PubMed ID: 2921504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension.
    Laviña B; Gracia-Sancho J; Rodríguez-Vilarrupla A; Chu Y; Heistad DD; Bosch J; García-Pagán JC
    Gut; 2009 Jan; 58(1):118-25. PubMed ID: 18829979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling.
    Reiberger T; Payer BA; Schwabl P; Hayden H; Horvatits T; Jäger B; Hummel T; Mitterhauser M; Trauner M; Fuhrmann V; Angermayr B; Peck-Radosavljevic M;
    Liver Int; 2013 Apr; 33(4):561-8. PubMed ID: 23331709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplantation of endothelial progenitor cells ameliorates vascular dysfunction and portal hypertension in carbon tetrachloride-induced rat liver cirrhotic model.
    Sakamoto M; Nakamura T; Torimura T; Iwamoto H; Masuda H; Koga H; Abe M; Hashimoto O; Ueno T; Sata M
    J Gastroenterol Hepatol; 2013 Jan; 28(1):168-78. PubMed ID: 22849788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Can mechanical augmentation of portal vein flow be an alternative treatment for portal hypertension and liver failure?].
    Havlík R; Jiao LR; Král V; Habib N
    Rozhl Chir; 1999 Sep; 78(9):461-4. PubMed ID: 11077876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the ligation of hepatic artery on the microcirculation in the cirrhotic liver in the rat.
    Koo A; Liang IY; Cheng KK
    Aust J Exp Biol Med Sci; 1976 Jun; 54(3):287-95. PubMed ID: 1016126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-frequency vagus nerve stimulation improves portal hypertension in cirrhotic rats.
    Bockx I; Verdrengh K; Vander Elst I; van Pelt J; Nevens F; Laleman W; Cassiman D
    Gut; 2012 Apr; 61(4):604-12. PubMed ID: 22187073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relation of periportal fibrosis to portal hypertension.
    Shibayama Y; Nakata K
    J Hepatol; 1990 Nov; 11(3):313-7. PubMed ID: 2290021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of portal hypertension and hepatic blood flow in cirrhotic rats by oestrogen.
    Sakamoto M; Ueno T; Nakamura T; Sakata R; Hasimoto O; Torimura T; Sata M
    Eur J Clin Invest; 2005 Mar; 35(3):220-5. PubMed ID: 15733078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in mechanical properties of mesenteric resistance arteries in experimental portal hypertension.
    Resch M; Wiest R; Moleda L; Fredersdorf S; Stoelcker B; Schroeder JA; Schölmerich J; Endemann DH
    Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G849-57. PubMed ID: 19696142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Rat Model of Repetitive Portal Venous Embolization Mimicking Human Non-Cirrhotic Idiopathic Portal Hypertension.
    Klein S; Hinüber C; Hittatiya K; Schierwagen R; Uschner FE; Strassburg CP; Fischer HP; Spengler U; Trebicka J
    PLoS One; 2016; 11(9):e0162144. PubMed ID: 27589391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Portal flow augmentation for liver cirrhosis.
    Jiao LR; Seifalian AM; Mathie RT; Habib N; Davidson BR
    Br J Surg; 2000 Aug; 87(8):984-91. PubMed ID: 10931040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversed portal flow: Clinical influence on the long-term outcomes in cirrhosis.
    Kondo T; Maruyama H; Sekimoto T; Shimada T; Takahashi M; Yokosuka O
    World J Gastroenterol; 2015 Aug; 21(29):8894-902. PubMed ID: 26269679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced portal hypertension by mechanical increase in liver portal blood flow.
    Burns E; Parsons MA; Bax ND
    Lancet; 1991 Mar; 337(8743):740-1. PubMed ID: 1672211
    [No Abstract]   [Full Text] [Related]  

  • 17. Computational hemodynamics of portal vein hypertension in hepatic cirrhosis patients.
    Li X; Wang XK; Chen B; Pu YS; Li ZF; Nie P; Su K
    Biomed Mater Eng; 2015; 26 Suppl 1():S233-43. PubMed ID: 26406008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased blood flow through the portal system in cirrhotic rats.
    Vorobioff J; Bredfeldt JE; Groszmann RJ
    Gastroenterology; 1984 Nov; 87(5):1120-6. PubMed ID: 6479534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intrahepatic portal vein compliance in cirrhosis].
    Zheng E; Leng X; Liu J; Xu Q; Peng J; Du R
    Zhonghua Wai Ke Za Zhi; 1998 Jun; 36(6):350-2. PubMed ID: 11825409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphological and biomechanical remodeling of the hepatic portal vein in a swine model of portal hypertension.
    He XJ; Huang TZ; Wang PJ; Peng XC; Li WC; Wang J; Tang J; Feng N; Yu MH
    Ann Vasc Surg; 2012 Feb; 26(2):259-67. PubMed ID: 22192237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.